A detailed history of Future Fund LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Future Fund LLC holds 40,175 shares of ADMA stock, worth $565,262. This represents 0.33% of its overall portfolio holdings.

Number of Shares
40,175
Holding current value
$565,262
% of portfolio
0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$17.6 - $24.51 $707,080 - $984,689
40,175 New
40,175 $731,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.76B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Future Fund LLC Portfolio

Follow Future Fund LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Future Fund LLC, based on Form 13F filings with the SEC.

News

Stay updated on Future Fund LLC with notifications on news.